Glaxosmithkline Pharmaceuticals Ltd Annually Results

Gross Sales

3,749.21

3,453.71

3,251.72

3,278.03

2,925.6

Excise Duty

0

0

0

0

0

Net Sales

3,749.21

3,453.71

3,251.72

3,278.03

2,925.6

Other Operating Income

0

0

0

0

0

Other Income

150.62

122.59

103.71

1,401.31

181.46

Total Income

3,899.83

3,576.3

3,355.43

4,679.34

3,107.06

Total Expenditure

2,571.85

2,688.63

2,448.4

2,516.15

2,500.06

PBIDT

1,327.98

887.67

907.03

2,163.19

607

Interest

1.31

1.8

1.81

2

3.53

PBDT

1,326.67

885.87

905.22

2,161.19

603.47

Depreciation

66.79

69.68

65.77

68.19

78.6

Minority Interest Before NP

0

0

0

0

0

Tax

325.96

237.59

247.13

407.69

158.67

Deferred Tax

6.34

-11.36

-18.37

-9.41

8.05

Reported Profit After Tax

927.58

589.96

610.69

1,694.72

358.15

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

927.58

589.96

610.69

1,694.72

358.15

Extra-ordinary Items

3.45

-101.81

1.79

1,319.47

-38.34

Adjusted Profit After Extra-ordinary item

924.13

691.77

608.9

375.25

396.49

EPS (Unit Curr.)

54.52

41.14

36.08

100.04

21.14

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

780

320

320

900

300

Equity

169.41

169.41

169.41

169.41

169.41

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

35.42

25.7

27.89

65.99

20.74

PBDTM(%)

35.38

25.64

27.83

65.92

20.62

PATM(%)

24.74

17.08

18.78

51.69

12.24